A quantitative review of nanotechnology‐based therapeutics for kidney diseases
WIREs Nanomedicine and Nanobiotechnology · 2024-03 · 16 (2)
DOI: 10.1002/wnan.1953 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift WIREs Nanomedicine and Nanobiotechnology, online erschienen am 18.03.2024. Verfasst von Hui-Teng Cheng und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, Zhu Bei City, Taiwan. Hauptthemen laut MEDLINE: Nanoparticles, Kidney Diseases. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 134 Literaturangaben. Gefördert von: Ministry of Science and Technology, National Tsing Hua University, Taiwan, National Taiwan University Hospital Hsin-Chu Branch.
Abstract (Originalsprache)
Kidney‐specific nanocarriers offer a targeted approach to enhance therapeutic efficacy and reduce off‐target effects in renal treatments. The nanocarriers can achieve organ or cell specificity via passive targeting and active targeting mechanisms. Passive targeting capitalizes on the unique physiological traits of the kidney, with factors like particle size, charge, shape, and material properties enhancing organ specificity. Active targeting, on the other hand, achieves renal specificity through ligand‐receptor interactions, modifying nanocarriers with molecules, peptides, or antibodies for receptor‐mediated delivery. Nanotechnology‐enabled therapy targets diseased kidney tissue by modulating podocytes and immune cells to reduce inflammation and enhance tissue repair, or by inhibiting myofibroblast differentiation to mitigate renal fibrosis. This review summarizes the current reports of the drug delivery systems that have been tested in vivo, identifies the nanocarriers that may preferentially accumulate in the kidney, and quantitatively compares the efficacy of various cargo‐carrier combinations to outline optimal strategies and future research directions. This article is categorized under: Nanotechnology Approaches to Biology > Nanoscale Systems in Biology Therapeutic Approaches and Drug Discovery > Emerging Technologies
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch, Zhu Bei City, Taiwan.
- Institute of Biomedical Engineering, National Tsing Hua University, Hsinchu, Taiwan.
- International Intercollegiate Ph.D. Program, National Tsing Hua University, Hsinchu, Taiwan.
- Department of Chemistry, National Tsing Hua University, Hsinchu, Taiwan.
ORCID-Profile: Hui-Teng Cheng, Yunching Chen
Förderung
- Ministry of Science and Technology
- National Tsing Hua University, Taiwan
- National Taiwan University Hospital Hsin-Chu Branch
- National Tsing Hua University
Zitieren
APA
Cheng, H. T., Ngoc Ta, Y. N., Hsia, T., & Chen, Y. (2024). A quantitative review of nanotechnology‐based therapeutics for kidney diseases. WIREs Nanomedicine and Nanobiotechnology, 16(2). https://doi.org/10.1002/wnan.1953
Vancouver
Cheng HT, Ngoc Ta YN, Hsia T, Chen Y. A quantitative review of nanotechnology‐based therapeutics for kidney diseases. WIREs Nanomedicine and Nanobiotechnology. 2024;16(2). doi:10.1002/wnan.1953
BibTeX
@article{Cheng2024,
author = {Cheng, Hui-Teng and Ngoc Ta, Yen-Nhi and Hsia, Tiffaney and Chen, Yunching},
title = {A quantitative review of nanotechnology‐based therapeutics for kidney diseases},
journal = {WIREs Nanomedicine and Nanobiotechnology},
year = {2024},
volume = {16},
number = {2},
doi = {10.1002/wnan.1953}
}
EUVIMED